Integrity Alliance’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.15M Sell
35,527
-1,849
-5% -$108K 0.08% 194
2025
Q4
$2.02M Buy
37,376
+28,348
+314% +$1.36M 0.07% 207
2025
Q3
$407K Buy
9,028
+748
+9% +$34.9K 0.02% 390
2025
Q2
$383K Sell
8,280
-8,601
-51% -$422K 0.02% 343
2025
Q1
$1.03M Buy
+16,881
New +$984K 0.04% 269

Other funds holding BMY

Integrity Alliance's BMY Position: Q1 2026 in Review

Integrity Alliance reduced its Bristol-Myers Squibb (BMY) stake by 4.9% in Q1 2026, selling an estimated $108K and leaving 35,527 shares worth $2.15M. The position accounts for 0.08% of the portfolio, ranked #194.

Integrity Alliance first reported a position in BMY in Q1 2025 and has held it in 5 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Integrity Alliance held 35,527 shares of Bristol-Myers Squibb worth $2.15M as of Q1 2026.
  • Integrity Alliance sold 1,849 Bristol-Myers Squibb shares in Q1 2026, an estimated $108K.
  • Bristol-Myers Squibb made up 0.08% of Integrity Alliance's portfolio in Q1 2026, its #194 holding.
  • Integrity Alliance first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 5 quarters since.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Integrity Alliance's 13F filing for Q1 2026, filed 11 May 2026.